Consultation Fee (200) (QA) at Dr. Essa Lab

Consultation Fee (200) (QA) at Dr. Essa Lab

The Consultation Fee (200) (QA) at Dr. Essa Lab represents a specialized clinical service designed to bridge the gap between complex diagnostic testing and actionable medical guidance. In modern healthcare, a laboratory report or diagnostic scan is only as valuable as its clinical interpretation. Dr. Essa Laboratory & Diagnostic Centre, a pioneer in pathology, radiology, and preventative healthcare in Pakistan, offers this structured consultation and quality assurance (QA) service to ensure patients receive expert clinical oversight. This fee covers a professional evaluation by a qualified medical officer or consultant, who reviews the patient’s diagnostic profile, correlates laboratory findings with clinical symptoms, and ensures that the highest standards of quality assurance are maintained throughout the diagnostic pathway.

By integrating this consultation service, Dr. Essa Lab ensures that patients are not left to interpret complex medical data on their own, thereby reducing clinical anxiety and preventing the misinterpretation of critical health indicators. The quality assurance component of this service involves a meticulous review of the diagnostic process, ensuring that the laboratory results align perfectly with the patient’s clinical presentation. This comprehensive approach is essential for establishing an accurate diagnosis, formulating an effective treatment plan, and determining whether further specialized investigations are required. Whether you are undergoing routine screening or investigating a complex medical condition, this clinical consultation provides the professional clarity needed to navigate your healthcare journey with confidence.

Clinical Procedure: What to Expect

Patient Preparation

To maximize the clinical utility of your Consultation Fee (200) (QA) at Dr. Essa Lab, appropriate preparation is highly recommended. Please adhere to the following guidelines:

• Document Compilation: Gather all previous medical records, including laboratory reports, radiology scans, discharge summaries, and historical clinical notes.
• Medication List: Prepare a complete list of all current medications, including dosages, active prescriptions, over-the-counter drugs, and dietary supplements.
• Symptom Log: Note down any active symptoms, their duration, severity, and any factors that alleviate or exacerbate them.
• Dietary Restrictions: No fasting is required for the consultation itself. However, if you plan to undergo concurrent laboratory tests during your visit, please follow the specific fasting guidelines for those investigations.
• Identification: Bring a valid government-issued identification document and any referral letters from your primary physician.

During the Procedure

Upon arriving at Dr. Essa Lab, you will undergo a structured clinical assessment designed to ensure safety, accuracy, and professional care:

• Registration: The administrative staff will register your details and collect any referral documents or previous reports.
• Triage and Vitals: A trained healthcare professional may record your baseline vital signs, including blood pressure, heart rate, respiratory rate, and body temperature.
• Consultant Interface: You will meet with a qualified clinical consultant or medical officer in a private, confidential consultation room.
• Clinical Interview: The consultant will conduct a detailed medical history interview, exploring your lifestyle, family medical history, and current health concerns.
• Diagnostic Reconciliation: The clinician will carefully review your diagnostic reports, cross-referencing the laboratory data with your physical symptoms to perform a comprehensive quality assurance check.
• Clinical Guidance: Based on the evaluation, the consultant will explain your results in clear, patient-friendly terms, outline potential diagnostic possibilities, and recommend appropriate next steps.
• Duration: The entire consultation and QA process typically takes 15 to 30 minutes, depending on the complexity of your medical history.

When is a Consultation Fee (200) (QA) Performed?

Interpretation of Complex Laboratory Profiles

When patients undergo comprehensive diagnostic panels, such as executive health profiles, hormone assays, or detailed metabolic screens, the resulting data can be highly intricate. Physicians request this consultation to systematically break down these parameters, explaining the clinical significance of elevated or depressed values. This ensures that subtle abnormalities are not overlooked and that the patient fully understands their metabolic and physiological status.

Pre-Test Clinical Triage and Guidance

Prior to undergoing expensive, specialized, or invasive diagnostic procedures, patients often require professional guidance to determine the most appropriate testing sequence. This consultation helps identify the exact diagnostic pathway needed based on the patient’s presenting symptoms, risk factors, and family medical history. By optimizing the test selection process, the clinician prevents unnecessary testing and ensures a cost-effective diagnostic journey.

Quality Assurance and Diagnostic Reconciliation

In cases where laboratory findings do not align with a patient’s clinical presentation, a quality assurance review is crucial. This process reconciles the objective data from the laboratory with the subjective symptoms of the patient. If a discrepancy is identified, the consultant initiates a QA protocol to verify pre-analytical, analytical, and post-analytical variables, ensuring that the final diagnostic conclusion is completely accurate and reliable.

Symptomatic Evaluation for Undiagnosed Illnesses

Patients presenting with vague, non-specific symptoms such as chronic fatigue, unexplained weight loss, persistent low-grade fever, or generalized joint pain benefit significantly from this structured consultation. The clinician uses this session to map these symptoms to specific physiological systems, helping to identify potential underlying conditions such as autoimmune disorders, chronic infections, or metabolic imbalances, and directing further targeted testing.

Post-Diagnostic Monitoring and Treatment Follow-Up

For patients managing chronic conditions like diabetes, hypertension, thyroid disorders, or dyslipidemia, regular diagnostic monitoring is mandatory. This consultation evaluates the longitudinal trends in the patient’s lab reports to assess treatment efficacy. The clinician reviews the data to determine if the current therapeutic intervention is achieving the desired clinical targets or if adjustments to medication and lifestyle are warranted.

What Does a Consultation Fee (200) (QA) Detect?

The Consultation Fee (200) (QA) is a comprehensive clinical evaluation that assists in the detection, correlation, and verification of numerous physiological and pathological states, including:

• Glycemic Imbalances: Correlation of elevated HbA1c or fasting blood glucose levels with clinical signs of insulin resistance or diabetes mellitus.
• Thyroid Dysfunction: Evaluation of thyroid-stimulating hormone (TSH) and free thyroid hormones to detect subclinical hypo- or hyperthyroidism.
• Cardiovascular Risk: Assessment of lipid profiles, blood pressure trends, and inflammatory markers to stratify cardiovascular disease risk.
• Hematological Abnormalities: Identification of microcytic, macrocytic, or normocytic anemias through complete blood count (CBC) and red cell indices.
• Systemic Inflammation: Detection of elevated acute-phase reactants such as C-reactive protein (CRP) and Erythrocyte Sedimentation Rate (ESR).
• Renal Impairment: Evaluation of glomerular filtration rate (GFR), serum creatinine, and blood urea nitrogen (BUN) to detect early-stage kidney dysfunction.
• Hepatic Stress: Assessment of liver enzymes (ALT, AST, ALP) and bilirubin to identify hepatocyte injury or biliary obstruction.
• Electrolyte Imbalances: Detection of abnormal sodium, potassium, or chloride levels that may contribute to cardiac arrhythmias or muscle weakness.
• Nutritional Deficiencies: Identification of critical vitamin deficiencies, particularly Vitamin D3 and Vitamin B12, impacting bone and neurological health.
• Gastrointestinal Pathology: Correlation of persistent abdominal symptoms with stool markers, occult blood, or inflammatory indicators.
• Urinary Tract Infections: Detection of active infections through the clinical correlation of urinalysis parameters like nitrites and leukocyte esterase.
• Metabolic Syndrome: Identification of clustering risk factors including abdominal obesity, dyslipidemia, hypertension, and impaired glucose tolerance.
• Coagulation Disorders: Evaluation of bleeding or clotting risks through the clinical review of prothrombin time (PT) and international normalized ratio (INR).
• Autoimmune Indicators: Correlation of joint pain or systemic symptoms with specific autoantibody screens like ANA or Rheumatoid Factor.
• Allergic Tendencies: Assessment of elevated immunoglobulin E (IgE) levels in patients presenting with chronic respiratory or dermatological symptoms.
• Hydration Status: Evaluation of hemoconcentration or hemodilution markers to assess systemic hydration levels.
• Medication Toxicity: Monitoring of therapeutic drug levels or organ function parameters to detect adverse drug reactions or toxicity.
• Bone Metabolism Issues: Assessment of calcium, phosphorus, and alkaline phosphatase levels to evaluate bone turnover and mineralization.
• Subclinical Infections: Detection of low-grade chronic infections through differential white blood cell counts and clinical history.
• Lifestyle-Induced Stressors: Identification of physiological markers of chronic stress, poor sleep, or inadequate nutrition.
• Uric Acid Accumulation: Evaluation of hyperuricemia to assess the risk of gouty arthritis or renal calculi.
• Pulmonary Correlation: Mapping of respiratory symptoms to relevant laboratory and imaging findings for comprehensive thoracic evaluation.
• Tumor Marker Surveillance: Clinical review of tumor marker trends in patients undergoing post-therapeutic monitoring or high-risk screening.
• Pedigree and Genetic Risks: Identification of familial disease patterns through detailed family history mapping during the consultation.
• Pre-Analytical Discrepancies: Detection and correction of laboratory anomalies caused by improper sample collection, transport, or processing.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Lab, the reporting and documentation process for the Consultation Fee (200) (QA) is streamlined for patient convenience. Following your consultation, a comprehensive clinical summary detailing the consultant’s findings, diagnostic interpretations, and recommended action plan is prepared immediately. This summary is integrated into your digital medical record. Patients can access their consultation notes and associated diagnostic reports securely online through the official Dr. Essa Lab web portal or mobile application. Additionally, printed copies of the consultation summary can be collected directly from the reception desk at any of our major diagnostic centers across Karachi and other cities. This rapid access to clinical documentation ensures that you can share your results with your primary healthcare provider without delay, facilitating timely medical decision-making.

Consultation Fee (200) (QA) Findings Overview

Parameter / Structure Evaluated	Normal Findings	Possible Abnormal Findings
Glycemic Control	Fasting Glucose < 100 mg/dL; HbA1c < 5.7%	Impaired Fasting Glucose (100-125 mg/dL); Diabetic Range (≥ 126 mg/dL); HbA1c ≥ 6.5%
Renal Function Indicators	Creatinine: 0.6-1.2 mg/dL; BUN: 7-20 mg/dL	Elevated Creatinine and BUN indicating acute kidney injury or chronic kidney disease
Hepatic Enzyme Profile	ALT: 7-56 U/L; AST: 10-40 U/L; Bilirubin: 0.2-1.2 mg/dL	Elevated transaminases indicating hepatocyte injury; Elevated bilirubin indicating cholestasis
Hematological Status	Hemoglobin: 12-16 g/dL (F), 13.5-17.5 g/dL (M); Normal WBC	Low Hemoglobin (anemia); Leukocytosis (infection/inflammation); Thrombocytopenia
Lipid Subfractions	Total Cholesterol < 200 mg/dL; LDL < 100 mg/dL	Hypercholesterolemia; Elevated LDL and Triglycerides indicating cardiovascular risk
Thyroid Regulatory Axis	TSH: 0.4-4.0 mIU/L; Normal Free T3 and T4	Elevated TSH (hypothyroidism); Depressed TSH with elevated free hormones (hyperthyroidism)
Electrolyte Balance	Sodium: 135-145 mEq/L; Potassium: 3.5-5.0 mEq/L	Hyponatremia/hypernatremia; Hypokalemia/hyperkalemia indicating metabolic risk
Quality Assurance Review	Perfect alignment between laboratory data and clinical presentation	Discrepancies requiring sample re-testing, clinical reconciliation, or further diagnostics

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Consultation Fee (200) (QA)?

• Legacy of Trust: Established in 1987 by renowned microbiologist Prof. Dr. Farhan Essa Abdullah, Dr. Essa Lab is one of Pakistan’s most trusted diagnostic networks.
• ISO 15189 Certification: Adheres to international quality management standards, ensuring the highest level of accuracy and reliability in diagnostic reporting.
• Expert Clinical Consultants: Access to highly qualified pathologists, radiologists, and clinical physicians for precise report interpretation.
• State-of-the-Art Technology: Equipped with advanced, fully automated laboratory systems and high-resolution diagnostic imaging modalities.
• Comprehensive QA Protocols: Rigorous internal and external quality control programs to validate the precision of every test result.
• Convenient Digital Access: Seamless online portal and mobile application for rapid report download and historical data tracking.
• Extensive Branch Network: Conveniently located collection centers and diagnostic clinics across Karachi and other major cities.
• Affordable Quality Care: Committed to making premium healthcare accessible through cost-effective services like the Consultation Fee (200) (QA).